SAPPHIRE THERAPEUTICS
Sapphire Therapeutics focuses on cancer supportive care and gastroenterology.
SAPPHIRE THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
Kaiyun Research Think
A research lab focused on neurology.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
The MacGill Centre
The MacGill Centre is a therapeutic centre that specialises in trauma recovery.
Current Advisors List
More informations about "Sapphire Therapeutics"
Revolutionary therapies for IBD and Celiac disease are
We are rethinking the approach to inflammatory bowel disease and Celiac disease by targeting novel, non-immunosuppressive pathways.See details»
Sapphire Therapeutics 2025 Company Profile: Valuation, Investors ...
How much funding has Sapphire Therapeutics raised over time? Sapphire Therapeutics has raised $59.5M. Who are Sapphire Therapeutics’s investors? BCM Ventures, BankInvest …See details»
Team - Sapphire
Sapphire therapeutics team. Contact Open main menu. Approach; Pipeline; Team; Careers; Team and Advisors. Team. Co-founder & CEO. Ildiko Mehes. 20+ year pharmaceutical …See details»
Our Story - Helsinn
A pivotal moment occurred in 2009, when Helsinn acquired Sapphire Therapeutics, which later became Helsinn Therapeutics (U.S.). This acquisition expanded our portfolio and strengthened …See details»
Sapphire | Approach
Specifically, targeting cytokines has proven to be modestly effective and lacking durability for patients, if they work at all. Inneffective Not only are current IBD drugs incredibly expensive, …See details»
Sapphire Therapeutics - Drug pipelines, Patents, Clinical trials
Explore Sapphire Therapeutics with its drug pipeline, therapeutic area, technology platform, 3 news.See details»
Sapphire Pharma | Leading health innovations. Impacting the world.
Sapphire Pharma Inc. is a global pharmaceutical company dedicated to developing and providing access to therapies for patients with infectious diseases, autoimmune conditions and women’s …See details»
Sapphire Therapeutics - Crunchbase Company Profile & Funding
Alternatives and possible competitors to Sapphire Therapeutics may include STipe Therapeutics, Polod Medtech, and Fujian Herui Genomics. Browse By: Organizations, People, Events Stay …See details»
Organization | Sapphire Therapeutics
Sapphire Therapeutics Report issue. For profit Phase 2. Founded: Bridgewater NJ United States ... Organization Overview. First Clinical Trial. 2005 NCT00219817. First Marketed Drug. None ...See details»
Sapphire Therapeutics - Crunchbase
Sapphire Therapeutics focuses on cancer supportive care and gastroenterology.See details»
Sapphire Therapeutics Inc - Company Profile and News
Company profile page for Sapphire Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Sapphire Therapeutics, Inc. - VentureRadar
Sapphire Therapeutics, Inc. VentureRadar profile. Find out more about Sapphire Therapeutics, Inc., Life sciences and Healthtech and Life Sciences.See details»
Sapphire Therapeutics - Contacts, Employees, Board Members, …
Sapphire Therapeutics focuses on cancer supportive care and gastroenterology.See details»
Sapphire Therapeutics - Overview, News & Similar companies
Who is Sapphire Therapeutics. Sapphire is a private biopharmaceutical company that inlicenses and develops promising small-molecule drug candidates to treat metabolic and oncolo gic …See details»
Sapphire Therapeutics - careersinpharmaceutical.com
Sapphire Therapeutics, located in Bridgewater, NJ, is a privately held biopharmaceutical company committed to developing and commercializing promising Drug candidates that are ready for …See details»
Sapphire Therapeutics - Products, Competitors, Financials, …
Sapphire is a biopharmaceutical company developing and commercializing promising compounds that are ready for clinical or pre-clinical testing in oncologic and metabolic disease. Use the CB …See details»
Helsinn acquires Sapphire Therapeutics - Manufacturing Chemist
Feb 4, 2009 The acquisition of Sapphire Therapeutics will also allow us to expand our current pipeline of products in existing, focused therapeutic areas." Sapphire Therapeutics was …See details»
Helsinn Buys Sapphire Therapeutics - Venture Capital Journal
Jan 29, 2009 Helsinn, a Swiss pharma group, has acquired Sapphire Therapeutics Inc., a Bridgewater, N.J.-based developer of drugs for a variety of cancer, gastrointestinal and …See details»
Helsinn Picks Up Sapphire Therapeutics to Establish U.S. Subsidiary
Jan 29, 2009 With this transaction, Helsinn has formed a U.S. subsidiary called Helsinn Therapeutics. The company points out that this acquisition helps it achieve its goal to establish …See details»
Nutcracker Therapeutics CEO Dr. Igor Khandros Retires as …
2 days ago EMERYVILLE, Calif., March 26, 2025--(BUSINESS WIRE)--Nutcracker Therapeutics, Inc., a contract, research, development and manufacturing organization …See details»